{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T06:25:01Z","timestamp":1771482301645,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":2413,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology of Japan","doi-asserted-by":"crossref","award":["#15K09089"],"award-info":[{"award-number":["#15K09089"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1111\/jth.13256","type":"journal-article","created":{"date-parts":[[2016,1,16]],"date-time":"2016-01-16T13:16:41Z","timestamp":1452950201000},"page":"850-859","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Assessment of platelet\u2010derived thrombogenicity with the total thrombus\u2010formation analysis system in coronary artery disease patients receiving antiplatelet therapy"],"prefix":"10.1016","volume":"14","author":[{"given":"Y.","family":"Arima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Kaikita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Sueta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Oimatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Tsujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Hokimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/jth.13256_bb0010","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/S0002-9149(99)00091-0","article-title":"Effects of aspirin and trapidil on cardiovascular events after acute myocardial infarction. Japanese Antiplatelets Myocardial Infarction Study (JAMIS) Investigators","volume":"83","author":"Yasue","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1111\/jth.13256_bb0015","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1161\/CIRCULATIONAHA.106.686048","article-title":"Incidence and predictors of drug\u2010eluting stent thrombosis during and after discontinuation of thienopyridine treatment","volume":"116","author":"Airoldi","year":"2007","journal-title":"Circulation"},{"key":"10.1111\/jth.13256_bb0020","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","article-title":"Incidence, predictors, and outcome of thrombosis after successful implantation of drug\u2010eluting stents","volume":"293","author":"Iakovou","year":"2005","journal-title":"JAMA"},{"key":"10.1111\/jth.13256_bb0025","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(05)67660-X","article-title":"Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo\u2010controlled trial","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/jth.13256_bb0030","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa050522","article-title":"Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST\u2010segment elevation","volume":"352","author":"Sabatine","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13256_bb0035","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jacc.2012.11.040","volume":"61","author":"Frelinger","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.13256_bb0040","doi-asserted-by":"crossref","first-page":"27A","DOI":"10.1016\/j.amjcard.2008.11.020","article-title":"Variability in responsiveness to oral antiplatelet therapy","volume":"103","author":"Angiolillo","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1111\/jth.13256_bb0045","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/35051599","article-title":"Identification of the platelet ADP receptor targeted by antithrombotic drugs","volume":"409","author":"Hollopeter","year":"2001","journal-title":"Nature"},{"key":"10.1111\/jth.13256_bb0050","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa0809171","article-title":"Cytochrome p\u2010450 polymorphisms and response to clopidogrel","volume":"360","author":"Mega","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13256_bb0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1055\/s-0037-1616935","article-title":"Assessment of platelet function in the laboratory","volume":"29","author":"Harrison","year":"2009","journal-title":"Hamostaseologie"},{"key":"10.1111\/jth.13256_bb0060","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/01.CIR.99.5.620","article-title":"Rapid platelet\u2010function assay: an automated and quantitative cartridge\u2010based method","volume":"99","author":"Smith","year":"1999","journal-title":"Circulation"},{"key":"10.1111\/jth.13256_bb0065","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1016\/j.thromres.2011.07.028","article-title":"Determination of cut\u2010off levels for on\u2010clopidogrel platelet aggregation based on functional CYP2C19 gene variants in patients undergoing elective percutaneous coronary intervention","volume":"128","author":"Ono","year":"2011","journal-title":"Thromb Res"},{"key":"10.1111\/jth.13256_bb0070","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/CIRCULATIONAHA.111.029165","article-title":"Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time\u2010dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: impact on Thrombosis and Safety (GRAVITAS) trial","volume":"124","author":"Price","year":"2011","journal-title":"Circulation"},{"key":"10.1111\/jth.13256_bb0075","first-page":"2510","article-title":"Three vs. twelve months of dual antiplatelet therapy after zotarolimus\u2010eluting stents: the OPTIMIZE randomized trial","volume":"310","author":"Feres","year":"2013","journal-title":"JAMA"},{"key":"10.1111\/jth.13256_bb0080","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1161\/CIRCULATIONAHA.111.059022","article-title":"Six\u2010month versus 12\u2010month dual antiplatelet therapy after implantation of drug\u2010eluting stents: the Efficacy of Xience\/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study","volume":"125","author":"Gwon","year":"2012","journal-title":"Circulation"},{"key":"10.1111\/jth.13256_bb0085","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30 months of dual antiplatelet therapy after drug\u2010eluting stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13256_bb0090","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.mvr.2011.11.007","article-title":"A microchip flow\u2010chamber system for quantitative assessment of the platelet thrombus formation process","volume":"83","author":"Hosokawa","year":"2012","journal-title":"Microvasc Res"},{"key":"10.1111\/jth.13256_bb0095","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1111\/j.1538-7836.2011.04464.x","article-title":"A novel automated microchip flow\u2010chamber system to quantitatively evaluate thrombus formation and antithrombotic agents under blood flow conditions","volume":"9","author":"Hosokawa","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13256_bb0100","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijcard.2015.06.041","article-title":"A novel quantitative assessment of whole blood thrombogenicity in patients treated with a non\u2010vitamin K oral anticoagulant","volume":"197","author":"Sueta","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1111\/jth.13256_bb0105","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/hmg\/2.2.159","article-title":"Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes\/swabs","volume":"2","author":"Richards","year":"1993","journal-title":"Hum Mol Genet"},{"key":"10.1111\/jth.13256_bb0110","doi-asserted-by":"crossref","first-page":"15419","DOI":"10.1016\/S0021-9258(17)40694-6","article-title":"The major genetic defect responsible for the polymorphism of S\u2010mephenytoin metabolism in humans","volume":"269","author":"de Morais","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13256_bb0115","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0009-9236(96)90214-3","article-title":"Genotyping of S\u2010mephenytoin 4\u2032\u2010hydroxylation in an extended Japanese population","volume":"60","author":"Kubota","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/jth.13256_bb0120","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1161\/CIRCINTERVENTIONS.112.000278","article-title":"Effects of endothelial dysfunction on residual platelet aggregability after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease","volume":"6","author":"Fujisue","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1111\/jth.13256_bb0125","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jjcc.2013.03.006","article-title":"Platelet reactivity in the early and late phases of acute coronary syndromes according to cytochrome P450 2C19 phenotypes","volume":"62","author":"Nagashima","year":"2013","journal-title":"J Cardiol"},{"key":"10.1111\/jth.13256_bb0130","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jacc.2009.10.043","article-title":"Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy","volume":"55","author":"Angiolillo","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.13256_bb0135","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/CIRCULATIONAHA.108.791061","volume":"118","author":"Wiviott","year":"2008","journal-title":"Circulation"},{"key":"10.1111\/jth.13256_bb0140","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1161\/CIRCULATIONAHA.109.866533","article-title":"Smoking, clopidogrel, and mortality in patients with established cardiovascular disease","volume":"120","author":"Berger","year":"2009","journal-title":"Circulation"},{"key":"10.1111\/jth.13256_bb0145","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1538-7836.2009.03644.x","article-title":"Adenosine diphosphate\u2010inducible platelet reactivity shows a pronounced age dependency in the initial phase of antiplatelet therapy with clopidogrel","volume":"8","author":"Gremmel","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13256_bb0150","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jama.2009.261","article-title":"Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome","volume":"301","author":"Ho","year":"2009","journal-title":"JAMA"},{"key":"10.1111\/jth.13256_bb0155","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1067\/mhj.2002.121734","article-title":"The Ultegra rapid platelet\u2010function assay: comparison to standard platelet function assays in patients undergoing percutaneous coronary intervention with abciximab therapy","volume":"143","author":"Wheeler","year":"2002","journal-title":"Am Heart J"},{"key":"10.1111\/jth.13256_bb0160","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1182\/blood-2012-02-413617","article-title":"Induction of functional platelets from mouse and human fibroblasts by p45NF\u2010E2\/Maf","volume":"120","author":"Ono","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.13256_bb0165","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1365-2516.2012.02867.x","article-title":"Evaluation of a novel flow chamber system to assess clot formation in factor VIII\u2010deficient mouse and anti\u2010factor IXa\u2010treated human blood","volume":"18","author":"Ogawa","year":"2012","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13256_bb0170","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.thromres.2013.05.026","article-title":"Studies of a microchip flow\u2010chamber system to characterize whole blood thrombogenicity in healthy individuals","volume":"132","author":"Yamaguchi","year":"2013","journal-title":"Thromb Res"},{"key":"10.1111\/jth.13256_bb0175","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1160\/TH11-04-0240","article-title":"A comparative study of prothrombin complex concentrates and fresh\u2010frozen plasma for warfarin reversal under static and flow conditions","volume":"106","author":"Ogawa","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13256_bb0180","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1160\/TH12-06-0441","article-title":"Analysing responses to aspirin and clopidogrel by measuring platelet thrombus formation under arterial flow conditions","volume":"109","author":"Hosokawa","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13256_bb0185","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMoa0808227","article-title":"Genetic determinants of response to clopidogrel and cardiovascular events","volume":"360","author":"Simon","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13256_bb0190","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(13)61170-8","article-title":"Platelet reactivity and clinical outcomes after coronary artery implantation of drug\u2010eluting stents (ADAPT\u2010DES): a prospective multicentre registry study","volume":"382","author":"Stone","year":"2013","journal-title":"Lancet"},{"key":"10.1111\/jth.13256_bb0195","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/jama.2010.181","article-title":"Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation","volume":"303","author":"Breet","year":"2010","journal-title":"JAMA"},{"key":"10.1111\/jth.13256_bb0200","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(08)61845-0","article-title":"Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study","volume":"373","author":"Collet","year":"2009","journal-title":"Lancet"},{"key":"10.1111\/jth.13256_bb0205","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jacc.2007.12.056","article-title":"Cytochrome P450 2C19 681G>A polymorphism and high on\u2010clopidogrel platelet reactivity associated with adverse 1\u2010year clinical outcome of elective percutaneous coronary intervention with drug\u2010eluting or bare\u2010metal stents","volume":"51","author":"Trenk","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.13256_bb0210","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jjcc.2014.07.016","article-title":"Comparison of the effect of CYP2C19 polymorphism on clinical outcome between acute coronary syndrome and stable angina","volume":"65","author":"Arima","year":"2015","journal-title":"J Cardiol"},{"key":"10.1111\/jth.13256_bb0215","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2133\/dmpk.20.300","article-title":"Genetic variations and haplotypes of CYP2C19 in a Japanese population","volume":"20","author":"Fukushima\u2010Uesaka","year":"2005","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1111\/jth.13256_bb0220","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jjcc.2010.10.007","article-title":"Impact of CYP2C19 polymorphism on residual platelet reactivity in patients with coronary heart disease during antiplatelet therapy","volume":"57","author":"Yamamoto","year":"2011","journal-title":"J Cardiol"},{"key":"10.1111\/jth.13256_bb0225","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1161\/CIRCGENETICS.113.000109","article-title":"CYP2C19 poor metabolizer is associated with clinical outcome of clopidogrel therapy in acute myocardial infarction but not stable angina","volume":"6","author":"Kim","year":"2013","journal-title":"Circ Cardiovasc Genet"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13256","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13256","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622046347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622046347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.13256\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:17:19Z","timestamp":1761535039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622046347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S1538783622046347"],"URL":"https:\/\/doi.org\/10.1111\/jth.13256","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of platelet\u2010derived thrombogenicity with the total thrombus\u2010formation analysis system in coronary artery disease patients receiving antiplatelet therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.13256","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}